Produced by Araxis Merge on 2/19/2018 2:07:57 PM Eastern Standard Time. See www.araxis.com for information about Merge. This report uses XHTML and CSS2, and is best viewed with a modern standards-compliant browser. For optimum results when printing this report, use landscape orientation and enable printing of background images and colours in your browser.
| # | Location | File | Last Modified |
|---|---|---|---|
| 1 | OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Package.zip\OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Package\OneVA_Pharmacy_CAS_MPDU_Build-2_Test_Cases | CAS_MPDU_TC_036_ Controlled Substance Order Management.docx | Mon Jan 8 17:12:56 2018 UTC |
| 2 | OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Package.zip\OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Package\OneVA_Pharmacy_CAS_MPDU_Build-2_Test_Cases | CAS_MPDU_TC_036_ Controlled Substance Order Management.docx | Mon Feb 19 18:08:50 2018 UTC |
| Description | Between Files 1 and 2 |
|
|---|---|---|
| Text Blocks | Lines | |
| Unchanged | 3 | 1150 |
| Changed | 2 | 4 |
| Inserted | 0 | 0 |
| Removed | 0 | 0 |
| Whitespace | |
|---|---|
| Character case | Differences in character case are significant |
| Line endings | Differences in line endings (CR and LF characters) are ignored |
| CR/LF characters | Not shown in the comparison detail |
No regular expressions were active.
| 1 | Department of Vetera ns Affairs | |
| 2 | ||
| 3 | Clinical A ncillary S ervices (C AS) | |
| 4 | ||
| 5 | ||
| 6 | Build 2 | |
| 7 | Sprint-3 | |
| 8 | Test Case CAS_TC_036 | |
| 9 | ||
| 10 | CLIN# 0004 AE | |
| 11 | December 2 017 | |
| 12 | Version 1. 0 | |
| 13 | Revision H istory | |
| 14 | Date | |
| 15 | Version | |
| 16 | Descriptio n | |
| 17 | Author | |
| 18 | 08/04/2017 | |
| 19 | 1.0 | |
| 20 | Initial dr aft | |
| 21 | Joseph A. McGovern | |
| 22 | Template R evision Hi story | |
| 23 | Date | |
| 24 | Version | |
| 25 | Descriptio n | |
| 26 | Author | |
| 27 | 08/04/2017 | |
| 28 | 1.0 | |
| 29 | Constructe d for CAS based on h istorical Test Case format use d on prior VA Projec ts | |
| 30 | Joseph A. McGovern | |
| 31 | ||
| 32 | ||
| 33 | Table of C ontents | |
| 34 | 1Product D escription 1 | |
| 35 | 1.1Purpose 1 | |
| 36 | 1.2Scope1 | |
| 37 | 2Test Case | |
| 38 | Appendix A .Acronyms & Abbrevia tions9 | |
| 39 | ||
| 40 | ||
| 41 | Product De scription | |
| 42 | OneVA Phar macy Clin ical Ancil lary Servi ces (CAS) project | |
| 43 | Purpose | |
| 44 | The purpos e of this document i s to devel op test ca se scenari os to iden tify, clar ify, and o rganize CA S applicat ion requir ements. Th e test cas e is made up of a se t of possi ble sequen ces of int eractions between sy stems and users in t he CHYSHR and DAYTSH R environm ents to va lidate and verify th at OneVA P harmacy so ftware Out patient Ph armacy Pre scription Processing will prov ide additi onal optio n(s) for s electing N on-Control led Substa nce medica tions and Schedule I II-V medic ations so that I can more effi ciently pr ocess the pending pr escription queue. | |
| 45 | . | |
| 46 | The CHYSHR environme nt is the Host site. The DAYT SHR enviro nment is t he dispens ing site ( remote). | |
| 47 | The test c ase should contain a ll system activities that have significa nce to the Pharmacis t users. | |
| 48 | Scope | |
| 49 | OneVA Phar macy softw are Outpat ient Pharm acy Prescr iption Pro cessing wi ll provide additiona l option(s ) for sele cting Non- Controlled Substance medicatio ns and Sch edule III- V medicati ons so tha t I can mo re efficie ntly proce ss the pen ding presc ription qu eue. | |
| 50 | Test Case | |
| 51 | CAS Test C ases and s upporting test scrip ts will be recorded managed in VA Enterp rise Jazz Rational Q uality Man ager Tool PBM(QM). Stakeholde rs can als o provide inputs abo ut the cur rent set o f test cas es as well as sugges t some mor e missing test cases . | |
| 52 | This test case will: | |
| 53 | Capture an d communic ate functi onal requi rements fo r software developme nt; and | |
| 54 | Provide a set of tes t inputs, execution conditions , and expe cted resul ts develop ed for a p articular objective, such as t o exercise a particu lar progra m path or to verify compliance with a sp ecific req uirement o r defect r emediation . | |
| 55 | ||
| 56 | ||
| 57 | Field | |
| 58 | Descriptio n | |
| 59 | Test Case ID: | |
| 60 | CAS_MPDU_T C_036_ Con trolled Su bstance Or der Manage ment | |
| 61 | RTC ID: | |
| 62 | 617018 | |
| 63 | RM ID: | |
| 64 | 949412 | |
| 65 | QM ID: | |
| 66 | 167735 | |
| 67 | Tester: | |
| 68 | Samatha Gi rla | |
| 69 | Environmen t: | |
| 70 | DAYTSHR | |
| 71 | Build : | |
| 72 | PSD_3_83_2 0171218A.K ID,PSO_7_5 05_2017121 9A.KID,PSS _1_219_201 71204B.KID ,XU_8_689_ 20171124B. KID | |
| 73 | Use Case N ame: | |
| 74 | Sort presc ription by supply it ems | |
| 75 | Scenario: | |
| 76 | As a pharm acist fini shing pres criptions, I need ad ditional o ption(s) f or selecti ng Non-Con trolled Su bstance me dications and Schedu le III-V m edications so that I can more efficientl y process the pendin g prescrip tion queue . | |
| 77 | Actors: | |
| 78 | Pharmacist | |
| 79 | Pre-Condit ion: | |
| 80 | The Pharma cist must have an ac tive VistA account w ith access to the On eVA Pharma cy Program . | |
| 81 | Patient sh ould have pending pr escription orders | |
| 82 | ||
| 83 | ||
| 84 | Post-Condi tion | |
| 85 | Upon entry of valid access and verify co des on Out Patient Ph armacy Pre scription Processing system wi ll prevent ed from is suing cont rolled sub stance pre scriptions that are missing th e zip code for the p atient’s a ddress | |
| 86 | ||
| 87 | Steps | |
| 88 | ||
| 89 | Pass | |
| 90 | Fail | |
| 91 | ||
| 92 | Actions | |
| 93 | Pass | |
| 94 | ||
| 95 | ||
| 96 | Log into y our local vista inst ance. | |
| 97 | ||
| 98 | ||
| 99 | ||
| 100 | Expected R esults | |
| 101 | ||
| 102 | ||
| 103 | ||
| 104 | User will be taken t o the acce ss/verify code promp ts. | |
| 105 | ||
| 106 | ||
| 107 | ||
| 108 | Actions | |
| 109 | Pass | |
| 110 | ||
| 111 | ||
| 112 | Enter your access/ve rify code( s). | |
| 113 | ||
| 114 | ||
| 115 | ||
| 116 | Expected R esults | |
| 117 | ||
| 118 | ||
| 119 | ||
| 120 | User it ta ken to the default m enu promp t. | |
| 121 | ||
| 122 | ||
| 123 | ||
| 124 | Actions | |
| 125 | Pass | |
| 126 | ||
| 127 | ||
| 128 | When promp ted ‘ISPA0 4:DAYTSHR> ’ D ^XUP | |
| 129 | :”, press <return> | |
| 130 | ||
| 131 | ||
| 132 | ||
| 133 | Expected R esults | |
| 134 | ||
| 135 | ||
| 136 | ||
| 137 | User is ta ken to the next prom pt. | |
| 138 | ||
| 139 | ||
| 140 | ||
| 141 | Actions | |
| 142 | Pass | |
| 143 | ||
| 144 | ||
| 145 | Select OPT ION NAME: PSO LMOE F INISH AND PRESS <Ret urn> | |
| 146 | ||
| 147 | ||
| 148 | ||
| 149 | Expected R esults | |
| 150 | ||
| 151 | ||
| 152 | ||
| 153 | System wil l ask to e nter divis ion | |
| 154 | ||
| 155 | ||
| 156 | ||
| 157 | Actions | |
| 158 | Pass | |
| 159 | ||
| 160 | ||
| 161 | Division:9 84 and Pre ss <Return > | |
| 162 | ||
| 163 | ||
| 164 | ||
| 165 | Expected R esults | |
| 166 | ||
| 167 | ||
| 168 | ||
| 169 | Select LAB EL PRINTER : HOME// SECURE Right Mar gin: 80// | |
| 170 | ||
| 171 | ||
| 172 | ||
| 173 | Actions | |
| 174 | Pass | |
| 175 | ||
| 176 | ||
| 177 | Press <Ret urn> until see the o ption Sele ct By: (P A/RT/PR/CL /FL/CS/SU/ E): PATIEN T// | |
| 178 | ||
| 179 | ||
| 180 | ||
| 181 | Expected R esults | |
| 182 | ||
| 183 | ||
| 184 | ||
| 185 | Select By: (PA/RT/P R/CL/FL/CS /SU/E): PA TIENT// | |
| 186 | ||
| 187 | ||
| 188 | 7 | |
| 189 | Actions | |
| 190 | Pass | |
| 191 | ||
| 192 | ||
| 193 | Select ‘CS ’ and pres s <Return > | |
| 194 | ||
| 195 | ||
| 196 | ||
| 197 | Expected R esults | |
| 198 | ||
| 199 | ||
| 200 | ||
| 201 | Route: (W /M/B/E): B OTH// | |
| 202 | ||
| 203 | ||
| 204 | 8 | |
| 205 | Actions | |
| 206 | Pass | |
| 207 | ||
| 208 | ||
| 209 | Press<Retu rn> | |
| 210 | ||
| 211 | ||
| 212 | ||
| 213 | Expected R esults | |
| 214 | ||
| 215 | ||
| 216 | ||
| 217 | Select a s chedule(s) | |
| 218 | ||
| 219 | Selec t one of t he followi ng: | |
| 220 | ||
| 221 | 1 SCHEDULE I I | |
| 222 | 2 SCHEDULES III - V | |
| 223 | 3 SCHEDULES II - V | |
| 224 | 4 NON-CS+SCH EDULES III - V | |
| 225 | 5 NON-CS ONL Y | |
| 226 | E EXIT | |
| 227 | ||
| 228 | Select Sch edule(s): 3// | |
| 229 | ||
| 230 | ||
| 231 | 9 | |
| 232 | Actions | |
| 233 | Pass | |
| 234 | ||
| 235 | ||
| 236 | Select NON -CS+SCHEDU LES III – V and pres s <Return> | |
| 237 | ||
| 238 | ||
| 239 | ||
| 240 | Expected R esults | |
| 241 | ||
| 242 | ||
| 243 | ||
| 244 | Would you like to se lect a sec ondary fil ter? N// | |
| 245 | ||
| 246 | ||
| 247 | 10 | |
| 248 | Actions | |
| 249 | Pass | |
| 250 | ||
| 251 | ||
| 252 | Press <Ret urn> | |
| 253 | ||
| 254 | ||
| 255 | ||
| 256 | Expected R esults | |
| 257 | ||
| 258 | ||
| 259 | ||
| 260 | Do you wan t to see M edication Profile? Y es// | |
| 261 | ||
| 262 | ||
| 263 | 11 | |
| 264 | Actions | |
| 265 | Pass | |
| 266 | ||
| 267 | ||
| 268 | Type No an d press <r eturn> | |
| 269 | ||
| 270 | ||
| 271 | ||
| 272 | Expected R esults | |
| 273 | ||
| 274 | ||
| 275 | ||
| 276 | Pending or ders that are for no n-controll ed substan ce medicat ions and S chedule II I-V contro lled subst ances shou ld be disp layed on t he screen | |
| 277 | ||
| 278 | INBERXSRTE STPATA,FNA (420-42-1 111) | |
| 279 | No Al lergy Asse ssment! | |
| 280 | ||
| 281 | Press Retu rn to cont inue: | |
| 282 | ||
| 283 | Remote dat a not avai lable - On ly local o rder check s processe d. | |
| 284 | ||
| 285 | Eligibilit y: SERVICE CONNECTED 50% to 10 0% SC% : 60 | |
| 286 | RX PATIENT STATUS: S C// | |
| 287 | ||
| 288 | Patient In formation Jan 03, 20 18@22:03:1 2 Page: 2 of 2 | |
| 289 | INBERXSRTE STPATA,FNA <NO ALLERGY A SSESSMENT> | |
| 290 | PID: 420 -42-1111 Ht(cm): _ ______ (__ ____) | |
| 291 | DOB: PII Wt(kg): __ _____ (___ ___) | |
| 292 | SEX: FEM ALE | |
| 293 | + | |
| 294 | Remo te: No rem ote data a vailable | |
| 295 | Adverse Re actions: | |
| 296 | ||
| 297 | ||
| 298 | ||
| 299 | Enter ?? f or more ac tions | |
| 300 | EA Enter/ Edit Aller gy/ADR Dat a PU Patien t Record U pdate | |
| 301 | DD Detail ed Allergy /ADR List EX Exit P atient Lis t | |
| 302 | Select Act ion: Quit/ / QUIT | |
| 303 | ||
| 304 | ||
| 305 | Jan 03, 20 18@22:03:1 5 | |
| 306 | ||
| 307 | Pending OP Orders (R OUTINE) Jan 03, 20 18@22:03:2 6 Page: 1 of 2 | |
| 308 | INBERXSRTE STPATA,FNA <NO ALLERGY A SSESSMENT> | |
| 309 | PID: 420 -42-1111 Ht(cm): _ ______ (__ ____) | |
| 310 | DOB: PII Wt(kg): __ _____ (___ ___) | |
| 311 | ||
| 312 | *(1) Order able Item: CETIRIZIN E TAB | |
| 313 | (2) CMOP Drug: CETIRIZIN E HCL 10MG TAB | |
| 314 | Dru g Message: TO BE USE D IN DOCUM ENTED CLAR ITIN FAILU RES ONLY 3 0 DAY | |
| 315 | LIMIT | |
| 316 | (3) *Dosage: 10 (MG) | |
| 317 | Verb: TAKE | |
| 318 | Dispe nse Units: 1 | |
| 319 | Noun: TABLET | |
| 320 | *Route: MOUTH | |
| 321 | *Schedule: TID | |
| 322 | (4) Pat Instruct: | |
| 323 | Provider Comments: | |
| 324 | Ins tructions: TAKE 1 TA BLET TID | |
| 325 | SIG: TAKE ONE TABLET BY MOUTH THRE E TIMES A DAY | |
| 326 | + Enter ?? f or more ac tions | |
| 327 | BY Bypass DC Discontinu e FL Flag /Unflag | |
| 328 | ED Edit FN Finish | |
| 329 | Select Ite m(s): Next Screen// | |
| 330 | ||
| 331 | Pending OP Orders (R OUTINE) Jan 03, 20 18@22:06:0 1 Page: 1 of 2 | |
| 332 | INBERXSRTE STPATA,FNA <NO ALLERGY A SSESSMENT> | |
| 333 | PID: 420 -42-1111 Ht(cm): _ ______ (__ ____) | |
| 334 | DOB: JAN 1,1975 (4 3) Wt(kg): _ ______ (__ ____) | |
| 335 | ||
| 336 | *(1) Order able Item: SILDENAFI L TAB | |
| 337 | (2) CMOP Drug: SILDENAFI L CITRATE 100MG TAB | |
| 338 | Dru g Message: RESTRICTE D TO PRIME CARE AND UROLOGY PH YSICIANS | |
| 339 | (3) *Dosage: 50 (MG) | |
| 340 | Verb: TAKE | |
| 341 | Dispe nse Units: 0.5 | |
| 342 | Noun: TABLET | |
| 343 | *Route: MOUTH | |
| 344 | *Schedule: bid | |
| 345 | (4) Pat Instruct: FOLLOW TH E PROVIDER INSTRUCTI ONS STRICT LY | |
| 346 | Provider Comments: | |
| 347 | Ins tructions: TAKE 0.5 TABLET bid | |
| 348 | SIG: TAKE ONE- HALF TABLE T BY MOUTH TWICE A D AY | |
| 349 | (5) Patie nt Status: SC | |
| 350 | + Enter ?? f or more ac tions | |
| 351 | BY Bypass DC Discontinu e FL Flag /Unflag | |
| 352 | ED Edit FN Finish | |
| 353 | Select Ite m(s): Next Screen// | |
| 354 | Pending OP Orders (R OUTINE) Jan 03, 20 18@22:06:2 9 Page: 1 of 2 | |
| 355 | INBERXSRTE STPATA,FNA <NO ALLERGY A SSESSMENT> | |
| 356 | PID: 420 -42-1111 Ht(cm): _ ______ (__ ____) | |
| 357 | DOB: JAN 1,1975 (4 3) Wt(kg): _ ______ (__ ____) | |
| 358 | ||
| 359 | *(1) Order able Item: TIMOLOL S OLN,OPH | |
| 360 | (2) CMOP Drug: TIMOLOL 0 .25% OPHTH SOLN 5ML ***(N/F)** * | |
| 361 | Dru g Message: This drug will not be process ed without Drug Requ est Form | |
| 362 | 10-7144 | |
| 363 | Verb: INSTILL | |
| 364 | (3) *Dosage: 2 DROPS | |
| 365 | *Route: BOTH EYES | |
| 366 | *Schedule: bid | |
| 367 | (4) Pat Instruct: good inst ructions | |
| 368 | Provider Comments: good comm ents | |
| 369 | Ins tructions: | |
| 370 | SIG: INSTILL 2 DROPS IN BOTH EYES TWICE A DA Y | |
| 371 | (5) Patie nt Status: SC | |
| 372 | (6) I ssue Date: MAR 1,201 7 ( 7) Fill Da te: JAN 3, 2018 | |
| 373 | + Enter ?? f or more ac tions | |
| 374 | BY Bypass DC Discontinu e FL Flag /Unflag | |
| 375 | ED Edit FN Finish | |
| 376 | Select Ite m(s): Next Screen// | |
| 377 | Pending OP Orders (R OUTINE) Jan 03, 20 18@22:06:5 8 Page: 1 of 2 | |
| 378 | INBERXSRTE STPATA,FNA <NO ALLERGY A SSESSMENT> | |
| 379 | PID: 420 -42-1111 Ht(cm): _ ______ (__ ____) | |
| 380 | DOB: JAN 1,1975 (4 3) Wt(kg): _ ______ (__ ____) | |
| 381 | ||
| 382 | *(1) Order able Item: BSS SOLN, OPH IRRG | |
| 383 | (2) Drug: BALANCED SALT SOLN 250ML | |
| 384 | Verb: IRRIGATE | |
| 385 | (3) *Dosage: nothing | |
| 386 | *Route: BOTH EYES | |
| 387 | *Schedule: bid | |
| 388 | (4) Pat Instruct: eye redne ss | |
| 389 | Provider Comments: maintain eye hygien e | |
| 390 | Ins tructions: | |
| 391 | SIG: IRRIGATE NOTHING BO TH EYES TW ICE A DAY | |
| 392 | (5) Patie nt Status: SC | |
| 393 | (6) I ssue Date: MAR 31,20 17 (7) Fill D ate: JAN 3 ,2018 | |
| 394 | (8) Da ys Supply: 90 ( 9) QTY ( BT): 90 | |
| 395 | Pro vider orde red 0 refi lls | |
| 396 | + Enter ?? f or more ac tions | |
| 397 | BY Bypass DC Discontinu e FL Flag /Unflag | |
| 398 | ED Edit FN Finish | |
| 399 | Select Ite m(s): Next Screen// | |
| 400 | Pending OP Orders (R OUTINE) Jan 03, 20 18@22:07:5 2 Page: 2 of 4 | |
| 401 | INBERXSRTE STPATA,FNA <NO ALLERGY A SSESSMENT> | |
| 402 | PID: 420 -42-1111 Ht(cm): _ ______ (__ ____) | |
| 403 | DOB: JAN 1,1975 (4 3) Wt(kg): _ ______ (__ ____) | |
| 404 | + | |
| 405 | ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- | |
| 406 | *(1) Order able Item: METHYLPRE DNISOLONE INJ,SUSP | |
| 407 | (2) Drug: METHYLPRE DNISOLONE ACETATE 40 MG/ML 1ML | |
| 408 | Verb: INJECT | |
| 409 | (3) *Dosage: NO | |
| 410 | *Route: SKIN | |
| 411 | *Schedule: BID | |
| 412 | (4) Pat Instruct: TESTING | |
| 413 | Provider Comments: TESTING | |
| 414 | Ins tructions: | |
| 415 | SIG: INJECT NO SKIN TWIC E A DAY TE STING | |
| 416 | (5) Patie nt Status: SC | |
| 417 | (6) I ssue Date: APR 30,20 17 (7) Fill D ate: JAN 3 ,2018 | |
| 418 | (8) Da ys Supply: 1 (9 ) QTY (V I): 1 | |
| 419 | + Enter ?? f or more ac tions | |
| 420 | BY Bypass DC Discontinu e FL Flag /Unflag | |
| 421 | ED Edit FN Finish | |
| 422 | Select Ite m(s): Next Screen// | |
| 423 | Pending OP Orders (R OUTINE) Jan 03, 20 18@22:08:5 1 Page: 3 of 5 | |
| 424 | INBERXSRTE STPATA,FNA <NO ALLERGY A SSESSMENT> | |
| 425 | PID: 420 -42-1111 Ht(cm): _ ______ (__ ____) | |
| 426 | DOB: JAN 1,1975 (4 3) Wt(kg): _ ______ (__ ____) | |
| 427 | + | |
| 428 | ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- | |
| 429 | *(1) Order able Item: CEFIXIME TAB ***(N/ F)*** | |
| 430 | (2) Drug: CEFIXIME 200MG TAB ***(N/F)** * | |
| 431 | Dru g Message: This drug will not be process ed without Drug Requ est Form | |
| 432 | 10-7144 | |
| 433 | Verb: TAKE | |
| 434 | (3) *Dosage: 1 | |
| 435 | *Schedule: BID | |
| 436 | *Duration: 5D (DAYS) | |
| 437 | (4) Pat Instruct: PRAVEEN T ESTING DAY TSHR | |
| 438 | Provider Comments: FBPPATIEN T MUST MAK E APPOINTM ENT | |
| 439 | Ins tructions: | |
| 440 | SIG: TAKE 1 TW ICE A DAY FOR 5 DAYS PRAVEEN T ESTING DAY TSHR | |
| 441 | (5) Patie nt Status: SC | |
| 442 | + Enter ?? f or more ac tions | |
| 443 | BY Bypass DC Discontinu e FL Flag /Unflag | |
| 444 | ED Edit FN Finish | |
| 445 | Select Ite m(s): Next Screen// | |
| 446 | ||
| 447 | ||
| 448 | ||
| 449 | 12 | |
| 450 | Actions | |
| 451 | Pass | |
| 452 | ||
| 453 | ||
| 454 | Press <Ret urn> until you compl ete revie w the avai lable pend ing orders | |
| 455 | ||
| 456 | ||
| 457 | ||
| 458 | Expected R esults | |
| 459 | ||
| 460 | ||
| 461 | ||
| 462 | <There are no flagge d orders f or DAYTSHR TEST LAB> | |
| 463 | ||
| 464 | Select By: (PA/RT/P R/CL/FL/CS /SU/E): PA TIENT// | |
| 465 | ||
| 466 | ||
| 467 | 13 | |
| 468 | Actions | |
| 469 | Pass | |
| 470 | ||
| 471 | ||
| 472 | Select ‘CS ’ and pres s <Return> | |
| 473 | ||
| 474 | ||
| 475 | ||
| 476 | Expected R esults | |
| 477 | ||
| 478 | ||
| 479 | ||
| 480 | Route: (W /M/B/E): B OTH// | |
| 481 | ||
| 482 | ||
| 483 | 14 | |
| 484 | Actions | |
| 485 | Pass | |
| 486 | ||
| 487 | ||
| 488 | Press <Ret urn> | |
| 489 | ||
| 490 | ||
| 491 | ||
| 492 | Expected R esults | |
| 493 | ||
| 494 | ||
| 495 | ||
| 496 | Select a s chedule(s) | |
| 497 | ||
| 498 | Selec t one of t he followi ng: | |
| 499 | ||
| 500 | 1 SCHEDULE I I | |
| 501 | 2 SCHEDULES III - V | |
| 502 | 3 SCHEDULES II - V | |
| 503 | 4 NON-CS+SCH EDULES III - V | |
| 504 | 5 NON-CS ONL Y | |
| 505 | E EXIT | |
| 506 | ||
| 507 | Select Sch edule(s): 3// | |
| 508 | ||
| 509 | ||
| 510 | 15 | |
| 511 | Actions | |
| 512 | Pass | |
| 513 | ||
| 514 | ||
| 515 | Select ‘5’ and press <Return> | |
| 516 | ||
| 517 | ||
| 518 | ||
| 519 | Expected R esults | |
| 520 | ||
| 521 | ||
| 522 | ||
| 523 | Would you like to se lect a sec ondary fil ter? N// | |
| 524 | ||
| 525 | ||
| 526 | 16 | |
| 527 | Actions | |
| 528 | Pass | |
| 529 | ||
| 530 | ||
| 531 | Press <Ret urn> | |
| 532 | ||
| 533 | ||
| 534 | ||
| 535 | Expected R esults | |
| 536 | ||
| 537 | ||
| 538 | ||
| 539 | Do you wan t to see M edication Profile? Y es// | |
| 540 | ||
| 541 | ||
| 542 | 17 | |
| 543 | Actions | |
| 544 | Pass | |
| 545 | ||
| 546 | ||
| 547 | Press <Ret urn> | |
| 548 | ||
| 549 | ||
| 550 | ||
| 551 | Expected R esults | |
| 552 | ||
| 553 | ||
| 554 | ||
| 555 | User can s ee patient s with Non -CS pendin g orders o nly | |
| 556 | ||
| 557 | ||
| 558 | ||
| 559 | ||
| 560 | ||
| 561 | ||
| 562 | ||
| 563 | Acronyms & Abbreviat ions | |
| 564 | Acronym | |
| 565 | Definition | |
| 566 | CAS | |
| 567 | Clinical A ncillary S ervices | |
| 568 | CHYSHR | |
| 569 | Test Envir onment fo r Host sit e | |
| 570 | CPRS | |
| 571 | Computeriz ed Patient Record Sy stem | |
| 572 | DAYTSHR | |
| 573 | Test Envir onment fo r the disp ensing sit e (remote) | |
| 574 | VHA | |
| 575 | Veteran’s Health Adm inistratio n | |
| 576 | VistA | |
| 577 | Veterans H ealth Info rmation Sy stems and Technology Architect ure |
Araxis Merge (but not the data content of this report) is Copyright © 1993-2016 Araxis Ltd (www.araxis.com). All rights reserved.